A detailed history of Cetera Trust Company, N.A transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Cetera Trust Company, N.A holds 2,580 shares of LGND stock, worth $295,771. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,580
Previous 2,555 0.98%
Holding current value
$295,771
Previous $215 Million 19.95%
% of portfolio
0.16%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$82.7 - $110.11 $2,067 - $2,752
25 Added 0.98%
2,580 $258 Million
Q2 2024

Aug 02, 2024

BUY
$68.53 - $87.91 $5,139 - $6,593
75 Added 3.02%
2,555 $215 Million
Q1 2024

May 08, 2024

BUY
$68.64 - $89.2 $18,876 - $24,530
275 Added 12.47%
2,480 $181 Million
Q4 2023

Feb 01, 2024

BUY
$49.57 - $72.63 $109,301 - $160,149
2,205 New
2,205 $157 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.94B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Cetera Trust Company, N.A Portfolio

Follow Cetera Trust Company, N.A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Trust Company, N.A, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Trust Company, N.A with notifications on news.